Den Europæiske Union - spansk - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - venetoclax - leucemia, linfocítica, crónica, b-cell - agentes antineoplásicos - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly  diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.

Den Europæiske Union - spansk - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - agentes antineoplásicos - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Ecuador - spansk - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

al pharma s.a.s colombia - cada vial contiene: azacitidina 100 mg - polvo liofilizado para suspension inyectable - cada vial contiene: azacitidina 100 mg

Peru - spansk - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

msn labs peru s.a.c. - droguerÍa - polvo para suspension inyectable - por vial 100.00 mg - - azacitidina

Chile - spansk - ISPC (Instituto de Salud Pública de Chile)

abbvie productos farmacÉuticos ltda. - venetoclax - sin formulas

Chile - spansk - ISPC (Instituto de Salud Pública de Chile)

abbvie productos farmacÉuticos ltda. - venetoclax - sin formulas

Chile - spansk - ISPC (Instituto de Salud Pública de Chile)

abbvie productos farmacÉuticos ltda. - venetoclax - sin formulas

Chile - spansk - ISPC (Instituto de Salud Pública de Chile)

abbvie productos farmacÉuticos ltda. - venetoclax - sin formulas

Den Europæiske Union - spansk - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leucemia, mieloide - agentes antineoplásicos - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.